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Abstract
Poisoning is a serious worldwide public health problem. Based on WHO data in 2012, 
almost 190,000 people died worldwide and the number of deaths due to poisoning in 2008 
exceeded the number of deaths due to motor vehicular crashes; also, poisoning death rate 
nearly tripled worldwide. Number of patients presenting to the emergency departments 
with overdose, had been increased both intentionally and accidentally. All the previous 
facts make Toxicology an important field in emergency medicine. Management of intoxi-
cated patients has a unique approach because of the challenge in diagnosis and treatment 
of overdose cases. This chapter is focusing on general approaches for intoxicated patients 
and initial management and on how the history and physical examinations could help 
physicians to have what drug have been abused as well as review the mechanism of 
action, physical finding and treatment of the most common drugs-causing toxicity in 
addition to the drugs with high mortality morbidity rates.
Keywords: approach, decontamination, toxidrome, acetaminophen, aspirin, cardiac 
drug toxicity, pesticides, toxic alcohol
1. Introduction
Poisoning is a serious worldwide public health problem. Based on World Health Organization 
(WHO) data in 2012, almost 190,000 people died worldwide and number of deaths due to poi-
soning in 2008 exceeded the number of deaths due to motor vehicular crashes; also, poisoning 
death rate nearly tripled worldwide. Number of patients presenting to the emergency depart-
ments with overdose, had been increased both intentionally and accidentally. All the previous 
facts make Toxicology an important field in emergency medicine [1, 2].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Management of intoxicated patients has a unique approach because of the challenge in diag-
nosis and treatment of overdose cases. This chapter is focusing on general approaches for 
intoxicated patients and initial management and on how the history and physical examina-
tions could help physicians to have what drug have been abused as well as review the mecha-
nism of action, physical finding and treatment of the most common drugs-causing toxicity in 
addition to the drugs with high mortality morbidity rates.
2. General approach to toxicological cases in emergency medicine
Approach for the poisoned patients in emergency includes: resuscitation, history, physical 
examination and management.
3. Resuscitation
The initial priorities for a poisoned patient presented emergency department are: securing 
the air-way and breathing and stabilizing the circulation. Inadequate ventilation may need 
intubation and mechanical ventilation. First-line treatment of hypotension is IV fluid bolus 
(10–20 mL/kg), if hypotension is not responding to fluid, it may be necessary to add specific 
antidote. If the patient presented with signs of opioid over dose (low Glasgow coma scale-
GCS respiratory depression, meiosis), give him naloxone (0.1–2.0 mg I.V), check blood sugar 
and treat hypoglycaemia with 50% 50 mL dextrose [3].
4. History
History is very important and can be obtained from the patient, and in case the patient is 
comatose or cannot give his history, we may take collateral information from family, friends 
or medical records looking for past psychiatry illness, previous history of suicide or drugs 
abuse, chronic medication… History must include time, route of entry, quantity, intentional 
or accidental exposure, availability of drugs at home and if any member of the family has 
chronic diseases (hypertension, diabetic etc…), missing tablets or any empty pill bottles or 
other material was found around him [4].
5. Physical examination
Physical examination of poisoned patients may give clues regarding the substance which has 
been abused and toxidromes. Physical examination includes: general appearance, mental status 
(agitated or confused), Skin (cyanosis, flashing, physical signs of intravenous drugs abuse (track 
marks), eyes: (pupil size reactivity lacrimation and nystagmus), odour (garlic, bitter almonds, 
glue, alcohol etc.…), Oropharynx hyper salivation or dryness, chest: breath sound, bronchor-
rhea, wheezing, heart rate, rhythm regularity), abdomen(bowel sound, tenderness, and rigidity), 
limbs(tremors and fasciculation), patient’s clothing (looking for any medications, illegal drugs) [3].
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6. Toxidromes
The term toxidrome was coined in 1970 by Mofenson and Greensher. Toxidromes are 
group of abnormal physical examination and abnormal vital signs known to present with 
specific group of medications or substances. Most common toxidromes are Cholinergic, 
Anticholinergic, Sympathomimetic, opioids, and serotonin syndrome [4, 5].
6.1. Cholinergics
Patients with cholinergic toxidrome present with wet manifestation. SLUDGE+3 killer B’s”or 
DUMBELLS are simple mnemonics for the common clinical symptoms.
“SLUDGE”: Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis + “Killer 
B’s”: Bronchorrhea, Bradycardia, and Bronchospasm.
“DUMBELLS”: Diarrhoea, Urination, Miosis (small pupils), Bradycardia, Emesis, Lacrimation, 
Lethargy, and Salivation.
Most common Causes: Organophosphate pesticides, Carbamates, Same type Mushrooms and 
Sarin (warfare agent) [4].
6.2. Anticholinergics
Patients with Anticholinergic toxidrome with dry manifestation, delirium, tachycardia, dry flushed 
skin, dilated pupils, clonus, elevated temperature, decreased bowl sounds, urinary retention. 
Simple mnemonics: “Hot as a Hare, Mad as a Hatter, Red as a Beet, Dry as a Bone, Blind as a Bat”.
Most common Causes: Antihistamines, antiparkinsonians, atropine, scopolamine, amanta-
dine, antipsychotics, antidepressants, muscle relaxants and plants (Jimson weed) [4].
6.3. Sympathomimetics
Patient present with CNS stimulation and psychomotor agitation, elevated blood pressure, 
tachycardia, dilated pupils, hyperthermia, diaphoresis and seizure in severe cases.
Most common causes: cocaine, amphetamine.
6.4. Opioids
Most common clinical presentation of opioids toxidrome are: coma, respiratory depression 
and meiosis, hypotension, hypothermia, bradycardia and seizure may occur in propoxyphene 
overdose, but small pupils not always present may present with normal size pupils such in 
meperidine and, propoxyphene toxicities [4].
6.5. Serotonin syndrome
Patient present with altered mental status, hypertensive, and tachycardia, Myoclonus hyper-
reflexia, hyperthermia and increase muscles rigidity. Most common causes: SSRI interaction 
or overdose [4].
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7. Decontaminations
Decontamination of poisoned patient means remove the patient from the toxin and remove 
the toxin from patient, either outside patient’s body by gross washing or inside the body by 
gastrointestinal decontamination or enhance elimination.
7.1. Gross decontamination
Patient must be fully undressed and washed thoroughly with copious amount of water; all 
the clothing must be removed, and decontamination must be in isolated specific area. Gross 
decontamination used in chemical, biological and radiation exposure.
7.2. Gastrointestinal decontamination
There are multiple methods used for gastrointestinal decontamination including:
Emesis and gastric Lavage.
Induced vomiting by ipecac syrup and gastric lavage: those methods were used in the past and 
now rarely indicated because there is no evidence supporting them. They can decrease absorp-
tion and they may also increase the risk of complications. Syrup ipecac and gastric Lavage may 
be considered in conscious, alert patients with ingestion of potentially number of toxic drugs 
and present in a very short time after ingestion (<1 h). Contradictions includes: unprotected 
airway, Corrosive/hydrocarbon ingestion and unstable patient status (hypotensive-seizure) [6].
7.3. Activated charcoal
Activated charcoal is super-heating carbonaceous material. Activated charcoal works by 
reducing the absorption of substance in the gastrointestinal lumen but it is not effective in 
metal, alcohols, corrosive, and lithium. Most effective action can be achieved when activated 
charcoal is given within the first hour of ingestion. Contraindications: absent gut motility 
or perforation, caustic ingestion and unprotected airway (can be given through nasogastric 
tube if patient intubated).Complications: aspiration of activated charcoal led to pneumonitis, 
ARDS and other complications such as small bowel obstruction [7].
7.4. Whole-bowel irrigation
Whole-bowel irrigation is a mechanical cleansing of the whole gastrointestinal track reducing 
toxin absorption. The whole-bowel irrigation can be done by Polyethylene glycol solution. 
Indication includes: substance with a prolonged absorption phase like sustained released 
medication, potential toxin not absorbed by activated charcoal such—(metals, lithium) and 
Body packers or suffers. Adverse effects of whole bowel irrigation could be: vomiting, bloat-
ing and rectal irritation. Contradiction: absent bowel sound or perforation [8].
7.5. Enhanced elimination
Enhanced elimination is a method used to increase the rate of toxic removal from the body so 
reducing the severity and duration of clinical intoxication.
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Enhanced elimination methods are not routinely used in poisoned patients. The indications 
for Enhanced elimination include [4]:
• Severe toxicity
• Poor outcome despite supportive care/antidote
• Slow endogenous rate of elimination
There are different techniques to enhance elimination:
Multiple dose activated charcoal (MDAC): it can be used in cases of carbamazepine, 
Phenobarbital, Dispone sever toxicities,
Urinary alkalinisation:
Can be used in cases of Salicylates Phenobarbitone.
Extracorporeal elimination (e.g. haemodialysis, hemofiltration, and haemoperfusion, plasma-
pheresis and exchange transfusion:
Can be used in cases of lithium, carbamazepine, salicylates, theophylline, and toxic.
Alcohols: ethylene glycol and methanol metformin.
7.6. Antidotes
Antidote is a substance that can prevent further poisoning from specific substances. The table 
below showing most common antidote used in emergency department (see Table 1) [4].
8. Acetaminophen poisoning
First time acetaminophen had been clinically used was in 1950 and since that time acet-
aminophen become most common over-the-counter antipyretic and analgesic used in public. 
Acetaminophen is the most common cause of acute liver failure in the United States [9, 10].
8.1. Mechanism of action
Acetaminophen metabolized in the liver and converted to nontoxic metabolites via glucuroni-
dation (40–67%) and sulfation (20–46%). In therapeutic doses of acetaminophen, the small 
amount of NAPQI formed which detoxified by conjugation with reduced glutathione (GSH). 
Glutathione is an important tripeptide which is reduced in a NADPH dependent reaction, 
and used to reduce oxidants (such as NAPQI).
In large overdoses of APAP, the usual pharmacokinetic pathways are overwhelmed and satura-
tion of the nontoxic pathways occurs. Endogenous glutathione is depleted and NAPQI cannot 
be detoxified. Leaving excess NAPQI to bind to intracellular proteins, cause cell death [11].
8.2. Clinical features
Symptoms are frequently nonspecific or absent in early Acetaminophen toxicity.
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Clinical presentation of Acetaminophen toxicity divided into four stages:
• Stage I (first 24 h): Patients may present nausea, vomiting, malaise, anorexia, or may be 
asymptomatic. Also hypokalaemia and metabolic acidosis can be found in blood test.
• -Stage II (Days 2–3): patients develop nausea, vomiting, right upper quadrant abdominal 
pain and laboratory evidence of hepatotoxicity. Aminotransferases (AST and ALT) elevate 
into thousands.
• -Stage III (3–4 days) defined by maximum hepatotoxicity, Patients exhibit coma, encepha-
lopathy, coagulopathy, renal failure, Jaundice, acute respiratory distress syndrome (ARDS), 
sepsis and cerebral oedema.
• -Stage IV (7–8 d): recovery or deterioration to multi-organ failure and death [12, 13].
Toxin Antidote
Acetaminophen N-acetylcysteine 150 mg/kg dextrose IV over 15–60 min then50 mg/kg 
NAC IV over 4 h. Then 100 mg/kg NAC IV over 16 h.
Cholinergic (organophosphates, 
carbamates)
Atropine 1–2 mg every 2–3 mins, until there is drying of secretions
Pralidoxime (2-PAM) 70 mg/kg IV then infusion at 500 mg/h
Anticholinesterases Physostigmine 0.5–1 mg IV as a slow push over 5 min and repeat every 
10 min
Benzodiazepines Flumazenil 0.2 Mg repeated max dose 2 mg
β-Blockers Glucagon 3–10 mg
Calcium channel blockers Calcium gluconate 10% 10–30 mL IV
Cyanide Amyl nitrite
Sodium thiosulfate
Sodium nitrite (3% solution)
Vitamin B12
Digoxin Digoxin Fab 5–10 vials
Isoniazid Pyridoxine (vitamin B6) 70 mg/kg IV (maximum 5 gm)
Methanol, ethylene glycol Ethanol Loading 8 mL/kg of 10% ethanol then 1–2 mL/kg/h of 10% 
ethanol
Fomepizole Loading: 15 mg/kg in 100 mL IV over 30 min
Maintenance: 10 mg/kg IV over 30 min every 12 h for 48 h
Narcotics Naloxone 0.1–0.4 mg, may repeated
Tricyclic antidepressants Sodium bicarbonate
1–2 mEq/kg IV bolus followed by 2 mEq/kg per h IV infusion
iron Desferrioxamine IV infusion dose of 15 mg/kg/h
methaemoglobinaemia Methylene Blue 1–2 mg/kg (0.1–0.2 mL/kg of 1% solution) IV slowly over 
5 min
local anaesthetics Intravenous lipid emulsion 1–1.5 mL/kg 20% IV bolus over 1 min Repeat 
bolus at 3–5 min
Then Infuse 0.25 mL/kg/min
Table 1. Antidote.
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8.3. Treatment
After initial support of airway, breathing and circulation, the clinician should consider gas-
trointestinal (GI) decontamination by activated charcoal. The cornerstone of acetaminophen 
overdose is N-acetylcysteine (NAC). NAC serves as a precursor to glutathione and may also 
directly reduce NAPQI. Clinical data suggest that if therapy is initiated within 8 h of inges-
tion, NAC is completely effective in preventing hepatotoxicity. Although NAC decreases in 
efficacy after 8 h, the drug has a benefit at all points in time, even for patients with fulminant 
hepatic failure.
N-acetylcysteine should only be given to patients with hepatotoxicity or risk of develop-
ing hepatotoxicity. The Rumack-Matthew nomogram is a tool for determining potential 
hepatotoxicity based on Acetaminophen level and time after ingestion. The nomogram 
is used to determine the risk for APAP hepatotoxicity for patients who present within 
24 h of an acute ingestion. Risk determination of hepatotoxicity becomes more difficult 
Figure 1. Rumack-Matthew nomogram.
Figure 2. ECG changes in TCA toxicity.
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when the nomogram is not applicable. Examples of such cases would be when the time 
of ingestion is unknown, when patients present more than 24 h after the ingestion and 
following ingestions that occur over many hours. In all of these cases NAC should be 
administered immediately. If aminotransferases (ALT, AST) are normal and APAP con-
centration is undetectable, the NAC may be discontinued. Otherwise, treatment with 
NAC should be continued.
N-acetylcysteine dose Oral 140 mg/kg loading dose 70 mg/kg q4 h × 17 doses or Intravenous 
150 mg/kg loading dose 50 mg/kg over 4 h 100 mg/kg over 16 h [14–16] (Figures 1 and 2).
9. Cyclic antidepressants (CA) poisoning
Cyclic antidepressants were used to depression, but now their use has reduced greatly because 
of the presences of more safe agents. Cyclic antidepressants were most common antidepres-
sants associated with overdose-related deaths in 2013 [17].
9.1. Mechanism of action
CA has multiple pharmacologic effects.
9.2. Antihistamine effects
Cyclic antidepressants are inhibiting postsynaptic histamine receptors, causing sedation, 
decrease level of conscious and coma.
9.3. Antimuscarinic effects
Antimuscarinic effects are divided to central and peripheral. Inhibition central acetylcholine 
receptors cause agitation, delirium, confusion, hallucinations, slurred speech, ataxia and coma. 
Inhibition Peripheral acetylcholine receptors inhibition cause dilated pupils, tachycardia, hyper-
thermia, hypertension, dry skin, ileus, urinary retention, increased muscle tone and tremor [18].
9.4. Inhibition of α-adrenergic receptors
This effects cause sedation, orthostatic hypotension, tachycardia and pupillary constriction, 
but because of the antimuscarinic effects, this action usually offsets pupillary dilatation [18].
9.5. Inhibition of amine reuptake
This effect produces mydriasis, diaphoresis, tachycardia, early hypertension, myoclonus and 
hyperreflexia.
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9.6. Inhibition sodium channel block
This effect produces decreased conduction velocity, increases the duration of repolarization 
and depressed myocardial contractility which lead to heart blocks, bradycardia and widening 
of the QRS complex [19].
9.7. Inhibition potassium channel block
This effect produces QT interval prolongation and rarely torsades de pointes can be seen [19].
9.8. Clinical features
Symptoms occur typically within 2 h of ingestion, which varies from mild antimuscarinic symp-
toms to severe cardio-toxicity. Patient may present with drowsiness, confusion, slurred speech, 
ataxia, sinus tachycardia, urinary retention, myoclonus and hyperreflexia. Serious toxicity is 
almost seen within 6 h of ingestion and patient present with: coma, cardiac conduction delays, 
supraventricular tachycardia, hypotension, respiratory depression, ventricular tachycardia and 
seizures [20, 21].
9.9. ECG changes in cyclic antidepressant poisoning
• Sinus tachycardia, most common
• Right axis deviation of the terminal 40 milliseconds positive terminal R wave in lead aVR 
and a negative S wave in lead I)
• Prolongation of QRS,(risk of seizures increases if the QRS complex is >100 milliseconds)
• Prolongation QT, PR
• Brugada pattern is seen 10–15%
9.10. Treatment
Treatment starts with supportive management securing airway, bolus i.v fluid in case of 
hypotension, GI decontamination with activated charcoal within 1 h of ingestion.
Add vasopressors if hypotensive refractory to IV normal saline. Cardiac conduction abnor-
malities, ventricular dysrhythmias, or hypotension refractory to IV fluid are indicated to 
start blood alkalization by Sodium bicarbonate Keep blood pH 7.50–7.55. Seizures, treat with 
Benzodiazepines if seizure refractory use Phenobarbital 10–15 mg/kg, The medication con-
traindication in CA toxicity are: Class I antiarrhythmic (lidocaine, phenytoin, and flecainide), 
Class III antiarrhythmic (amiodarone, sotalol), Β-blockers, Ca channel blockers, Physostigmine 
and Flumazenil [22, 23].
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10. Salicylate (aspirin) poisoning
Aspirin is the most common analgesic antiplatelet therapy used in cardiovascular and cere-
brovascular disease. Aspirin is over-the-counter drugs and widespread used lead to acciden-
tal and intentional toxicity [24].
10.1. Mechanism of action
Salicylate Inhibit cyclooxygenase leads to decreased synthesis of prostaglandins; prostacyclin 
and thromboxane. It also leads to platelet dysfunction and gastric mucosal injury. Salicylate 
Stimulate the chemoreceptor trigger zone in the medulla which causes nausea and vomiting. 
Also activate respiratory centre of the medulla leading to hyperventilation and respiratory 
alkalosis. Uncoupling of oxidative and Inhibit the Krebs which lead to metabolic acidosis [25].
10.2. Clinical features
Salicylate toxicity divided to acute and chronic toxicities.
10.3. Acute toxicity
Acute salicylate toxicity manifests initially through GI, CNS effects and metabolic effects. 
Gastric irritation, vomiting and nausea may predominate early in the course and are more 
predominant in the acute poisoning. Rising CNS salicylate concentrations produce tinnitus, 
diminished auditory acuity, vertigo and hyperventilation. As the poisoning continues, the 
CNS effects may progress to agitation, hallucinations, delirium, seizure and lethargy. The 
metabolic effects of salicylate toxicity cause uncoupling of oxidative phosphorylation leading 
to temperature elevation (an indicator of severe toxicity) and a large anion gap metabolic 
acidosis. Subsequent squeal of salicylate toxicity include renal failure, acute lung injury and 
platelet dysfunction.
10.4. Chronic toxicity
In contrast, chronic poisoning occurs over a longer period of time, when patients ingest more 
drug than they can eliminate over a prolonged period. These patients tend to be older and the 
overdose is unintentional. The initial presenting signs and symptoms include those of acute toxic-
ity although with slower onset and lesser severity. Chronic toxicity may easily be confused in the 
elderly for sepsis, ketoacidosis, delirium, dementia, CHF or respiratory failure. Diagnostic delay 
in the chronically poisoned patient has been shown to cause increased morbidity and mortality.
10.5. Treatment
Stabilization of the airway, breathing and circulation are the first steps in management. 
Intubation may increases the severity of the aspirin toxicity, so it is better to be avoided, 
but if intubation is necessary patients need appropriately high minute ventilation sitting. In 
case of volume depleted and acidosis, start treatment with I. V fluid. Gastrointestinal decon-
tamination with Activated charcoal may help in early ingestion. Whole bowel irrigation 
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(WBI) is useful in case of massive ingestions or sustained preparation or enteric-coated. Sever 
Salicylate toxicity treated with serum Alkalinisation by sodium bicarbonate with a aim of a 
serum pH of ~7.5.Patients may need haemodialysis and the indications for haemodialysis 
are clinical deterioration, severe acid-base disturbance, altered mental status, and acute lung 
injury, failure of serum and urine alkalinisation and renal failure [26–28].
11. Opioids poisoning
Opioid abuse is a significant medical and social problem in the world. In the past 10 years, 
the number of abuses and deaths from opioid overdoses had been increased. Opioids are all 
substances related to opium. They have analgesic and sedative effects. Opiate is extracted 
from the poppy plants [29].
11.1. Mechanism of action
There are three main opioid receptors: μ (mu), κ (kappa), and δ (delta), and Opioids have 
agonists effect on this receptors. Stimulation of opioids receptors will cause miosis, respira-
tory depression, cough suppression, euphoria and decreased GI motility.
11.2. Clinical features
Classic signs of opioid intoxication toxidrome, depressed mental status, decreased respira-
tory rate miosis, (constricted) pupils. Other finding includes: decreased bowel sounds ortho-
static hypotension, urinary retention and localized urticaria. Normal pupil examination can 
be seen, meperidine diphenoxylate, propoxyphene toxicity and co-ingestion of other toxin 
such as sympathomimetic or anticholinergic.
Same opioids have specific clinical feature (Table 2) [30, 32]:
Opioids agent Specific clinical feature
Dextromethorphan Serotonin toxicity; at high doses
Loperamide QRS and QT prolongation; Wide-complex tachycardia
Meperidine Seizure, normal pupils size
Serotonin syndrome (in combination with other agents)
Methadone long-acting;
QT prolongation, Torsade de Pointes
Oxycodone QT interval prolongation
Tramadol Seizure
Heroin Acute lung injury
Body packing: swallowing packets or containers of drug for the purposes of smuggling.
Body stuffing: swallowing of a smaller quantity of drug because of fear of arrest.
Table 2. Opioids with specific clinical feature.
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11.3. Treatment
Secure Airway and maintain adequate oxygenation and ventilation by using bag-valve mask 
are the first important steps in treatment; serum glucose should be checked. After that admin-
ister naloxone 0.4 mg IV, in non-opioid-dependent with minimal respiratory depression abut 
if patient is opioid-dependent present with minimal respiratory depression, administer small 
dose of naloxone, 0.1 mg IV, because larger doses can induce opioid withdrawal symptoms. 
Patients presenting with apnea or near-apnea and cyanosis, start naloxone, 2 mg IV regardless 
of drug use history, can be repeated IV every 3 min [30–32].
12. Sympathomimetic (cocaine) poisoning
Cocaine is one of the most potent Sympathomimetic, extracted from the leaves of the coca by 
indigenous to South America; therapeutically, first time Cocaine was used in 1884 as a local 
anaesthetic for ophthalmologic procedures. In the United States Cocaine is one of the most 
common causes of acute drug-related emergency department visits.
12.1. Mechanism of action
Cocaine stimulates alpha and adrenergic receptors by increasing levels of norepinephrine, 
causing vasoconstriction in cardiovascular system, also inhibits neuronal serotonin reup-
take which lead to euphoria. Cocaine blocks Sodium (Na+) channel causing QRS interval 
prolongation [33, 34].
12.2. Clinical features
Cocaine toxicity may cause sympathomimetic and vasoconstrictive effects on variety systems 
(cardiovascular, CNS …etc.).
Cardiovascular: patients with cocaine toxicity present with high blood pressure and dys-
rhythmias include tachycardia, such as sinus tachycardia, SVT, and AF. ECG changes include 
rightward shift of the terminal portion of the QRS complex and prolongation the QT interval. 
Patients may present with acute coronary syndromes (cocaine-associated acute coronary 
syndrome), aortic and coronary artery dissection, myocarditis and cardiomyopathy. CNS: 
patients with Cocaine present with a variety CNS clinical features including: agitation, sei-
zures, and coma. Pulmonary: mainly seen in patients who smoke crack cocaine includes pul-
monary haemorrhage, barotrauma, pneumonitis and asthma.
Gastrointestinal: Cocaine may cause intestinal ischemia, bowel necrosis and ischemic colitis, 
also increase risk for bleeding and ulcer perforation. Renal: acute kidney failure may occur 
because of rhabdomyolysis [35–37].
12.3. Treatment
Securing the airway and adequate breathing are initial steps in treatment. CNS manifestation 
(agitation, seizure) treated with sedation by Benzodiazepines, patient with Hyperthermia 
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should be cooled rapidly, severe hypertension not responding to sedation can be treated with 
a sodium nitroprusside infusion or phentolamine; (avoid Β-ac blockers). Cocaine toxicity with 
acute coronary syndrome are treated with aspirin and nitroglycerin also may add calcium 
channel blockers, wide-complex tachycardia with cocaine toxicity treated with serum alka-
linisation by sodium bicarbonate, make sure serum Ph do not exceed 7.55. Intravenous lipid 
emulsion can be used in severe cocaine toxicity, with refractory cardiovascular instability or 
refractory wide-complex tachycardia [37].
13. Digitalis glycosides poisoning
Cardiac glycosides were used in treatment of heart failure since long time. Since 1785 glyco-
sides found in plants like lily of the valley foxglove and oleander. Digoxin is most common 
digitalis drug used today for treatment of atrial fibrillation and congestive heart failure [38].
13.1. Mechanism of action
Digoxin inhibits Na + -K + -ATPase during repolarization which leading to increase in intra-
cellular sodium and a decrease in intracellular potassium leading to increase in the intracellu-
lar concentration of calcium causing Positive inotropic, also increase automaticity and shorten 
the repolarization intervals of the atria and ventricles [39].
13.2. Clinical features
Digoxin toxicity divided to acute and chronic toxicities.
13.3. Acute toxicity
The cause of acute toxicity is usually intentional or accidental ingestion, symptoms usually 
abrupt in onset, patients present with nausea, vomiting, non-specific abdominal pain, head-
ache and dizziness. Sever toxicity may cause confusion and coma, Bradydysrhythmia and 
atrioventricular block or supraventricular tachydysrhythmia and hyperkalaemia. Xanthopsia 
is a classic eye future in digoxin toxicity (viewing yellow-green halos around objects), but 
the most common finding is nonspecific changes in their colour vision. Serum digoxin level 
usually marked elevated [40, 41].
13.4. Chronic toxicity
Chronic toxicity is commonly and mainly seen in elderly patients and common causes are 
interaction with other medications (calcium channel antagonists, amiodarone, β-receptor 
antagonists, and diuretics) or renal insufficiency which causes decree the clearance of digoxin.
In contract of acute toxicity, where Gastrointestinal symptoms are prominent in chronic 
toxicity CNS symptoms (weakness, fatigue, confusion, or delirium) are more prominent. 
Ventricular dysrhythmias are commonly seen in chronic toxicity. Serum potassium level can 
be normal or decreased, also serum digoxin level usually minimally elevated [40, 41].
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Location Action Antagonism
B1 Myocardium
Kidney
Eye
Increases inotropy
Increases chronotropy
Stimulates renin release
Decreases inotropy
Decreases chronotropy
Inhibits renin release
B2 Bronchial smooth muscle
Skeletal muscle
Liver
Vascular
bronchodilation
Relaxes uterus
Increases force of contraction
Stimulates glycogenolysis and 
gluconeogenesis
Vasodilation
Causes bronchospasm
Inhibits glycogenolysis and 
gluconeogenesis
Minimal vasoconstriction
B3 Adipose tissue
Skeletal muscle
Stimulates lipolysis
Stimulates thermogenesis
Inhibits lipolysis
Inhibits thermogenesis
Table 3. Beta receptor: Locations and actions.
13.5. Treatment
General supportive care is an Initial step in treatment of digoxin toxicity; it includes securing 
airway and adequate ventilation and boluses of fluid IV in case of hypotension. Activated 
charcoal helps in early acute ingestion [42], Atropine can be given in case of Symptomatic 
bradycardia). Digoxin-specific antibody fragments (digoxin-Fab) are antidotes for digoxin. 
The indication to use (digoxin- Fab) includes Life-threatening dysrhythmias unresponsive to 
standard therapy and hyperkalaemia excess 6 mEq/L. [43] Digoxin-Fab doses are based on the 
total-body load of digoxin, which can be calculated from either the estimated dose ingested or 
the serum digoxin level, each vial of Digoxin-Fab reverses approximately 0.5 mg of ingested 
digoxin. If the amount of ingested digitalis is unknown, digoxin Fab 10 vials for adults empir-
ically can be given. Hyperkalaemia is treated with insulin, dextrose, sodium bicarbonate. The 
use of calcium salts in digoxin induced hyperkalaemia is controversial because old literature 
shows increase incidence of ventricular dysrhythmias and increase mortality [44].
14. Beta-blockers poisoning
Beta adrenergic antagonists (beta blockers) are groups of medications which have been used 
in treatment of different cardiovascular, neurological and ophthalmological diseases more 
than 30 years, Bête blockers toxicity has significant morbidity and mortality [17].
14.1. Mechanism of action
Beta receptors are divided by location and action to beta 1, beta 2, and beta 3 (see the Table 3).
There are two groups of beta-blockers: selective and non-selective.
Competitive antagonism of the beta receptor decreases cellular levels of cyclic adenosine mono-
phosphate (cAMP). Beta-1 selective blocker causing in depressed myocardial contractility, 
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decreased automaticity in pacemaker cells, and decreased conduction through the AV node. 
Non- selective beta blockade results in systemic effects including bronchoconstriction, impaired 
gluconeogenesis and decreased insulin release. Same Beta blockers (e.g., propranolol) have 
high lipid solubility leading to rapid cross of the blood brain barrier into the central nervous 
system, causing a neurological manifestation such as seizures and delirium [45, 47].
14.2. Clinical features
The major system affected by β-blocker toxicity is the cardiovascular system; patients present 
with bradycardia and hypotensive. The cause of bradycardia is sinus node suppression or 
conduction abnormalities but ingestion of β-blockers with partial agonist activity may cause 
hypertension and tachycardia as early presentation. The β-blockers with sodium channel 
block affect may cause a wide-complex bradycardia.
Sotalol causes potassium channels block leading to prolonging the QT interval.
Β-Blockers also have effect on CNS and pulmonary system. Neurologic features include delir-
ium, coma and seizures with more lipophilic. Β-blockers (propranolol) have more neurologi-
cal manifestations. Bronchospasm and hypoglycaemia can be in β-blockers toxicity [47, 48].
14.3. Treatment
GI decontamination can be done by giving Activated charcoal within 1 h of ingestion and air way 
is the main aim treatment in beta-blocker toxicity focusing on restore perfusion to critical organ 
systems by increasing cardiac output by: fluid resuscitation and glucagon (3–10 mg), vasopres-
sor (e.g., epinephrine) and high dose Insulin- glucose (insulin 1 unit/kg IV bolus). Intravenous 
lipid emulsion therapy may be used in case of sever toxicity and refractory to treatment. In 
case of refractory to pharmacologic therapy, haemodialysis, haemoperfusion, cardiac pacing, 
placement of intra-aortic balloon pumps can be used. Wide QRS-interval dysrhythmias due to 
sodium channel blockade treated with sodium bicarbonate 2–3 mEq/kg over 1–2 min [49, 50].
15. Calcium channel blocker poisoning
Calcium channel blockers (CCBs) are mainly used in the treatment of cardiovascular dis-
eases such as hypertension, coronary artery disseise- CAD and cardiac arrhythmias Calcium 
channel blockers one most prescribed cardiovascular drugs and can be immediate-release or 
extended-release [17].
15.1. Mechanism of action
The calcium channel blockers (CCBs) can be divided into two major groups based upon 
their major physiologic effects: the dihydropyridines, group which mainly block the L-type 
calcium channels in the vasculature and the non-dihydropyridines, which selectively block 
L-type calcium channels in the myocardium such as verapamil. Dihydropyridine group toxic-
ity causes arterial vasodilation and reflex tachycardia, whereas non-dihydropyridines toxicity 
cause peripheral vasodilation decreased cardiac inotropy, and bradycardia [46].
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15.2. Clinical features
Cardiovascular system is the most affected system in CCBs toxicity. Patient present with 
hypotension and bradycardia or reflex tachycardia. Verapamil or diltiazem toxicity usu-
ally patients present with sinus bradycardia, on the hand dihydropyridine overdoses cause 
peripheral vasodilatation causing reflex tachycardia [55]. CCBs have not primary effect on 
pulmonary and CNS System; CNS symptoms (seizures, delirium, and coma) occur secondary 
to decrease organ perfusion. Cardiogenic pulmonary oedema and acute lung injury (non-
cardiogenic pulmonary oedema) have also been reported in severe toxicity [48].
15.3. Treatment
First step in management is secure airway, stabilize ventilation and circulation.
Decontamination can be done by oral activated charcoal if patient present within 1 h of inges-
tion also the whole-bowel irrigation is useful in case of extended-release CCBs. Hypotension 
treated with IV fluid, Calcium chloride or calcium gluconate, glucagon (3–10 mg), if not 
responding start Vasopressors (e.g., norepinephrine). If symptoms refractory to vasopressor 
therapy start, high dose Insulin -glucose. If patient still not responding, lipid emulsion can be 
started. Finally, circulatory support measures, such as the placement of intra-aortic balloon 
pumps may be used in case of sever toxicity not responding to standard therapy [49–51].
16. Carbon monoxide poisoning
Carbon monoxide (CO) is an odourless, tasteless, colourless and non-irritating gas.
Potential sources of Carbon monoxide (CO) are automotive exhaust, fuelled heaters, Wood- 
or coal-burning stoves, Structure fires and gasoline-powered generators other than fires.
The incidence of co -poisoning increases during winter time because the use of space heaters, 
wood-burning stoves and charcoal burning for heat.
16.1. Mechanism of action
Carbon monoxide (CO) diffuses fast in the pulmonary capillary membrane and because of 
his rapid binding affinity (more than oxygen by 200 times), carbon monoxide bind to haemo-
globin, that cause impaired releasing oxygen to tissue leading to shift the oxyhaemoglobin 
dissociation curve to the left [51].
16.2. Clinical features
Carbon monoxide poisoning have variable clinical picture depend on severity of exposure 
ranging from non-specific symptoms like headache, nausea and dizziness in mild to moder-
ate cases to confusion, seizure and coma in severe cases patients may present with mild fever, 
tachycardia, tachypnoea and hypertension. Acute myocardial injury and life-threatening 
dysrhythmias are the most cardiovascular complications in case of severe Carbon monoxide 
poisoning. Delayed neuropsychiatric syndrome is long term neurological complication in 
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severe cases characterized with different symptoms including cognitive deficiency, move-
ment disorders and focal neurologic deficit. The standard pulse oximetry cannot differenti-
ate carboxyhaemoglobin from oxyhaemoglobin, so it is unreliable in the diagnosis or screen 
carbon monoxide poisoning, so measuring carboxyhaemoglobin level in an arterial blood gas 
helps in diagnosis [52–55].
16.3. Treatment
After securing the airway, the most important step in treatment is oxygen 100% via non-
rebreathing mask or intubation and mechanically ventilation with 100% oxygen if the patient 
is comatose and cannot secure his air way, half-life of carboxyhaemoglobin in room air 
250–320 min while via non-rebreathing with 100% oxygen decreased to 90 min. Hyperbaric 
oxygen therapy could be considered in certain cases, the indication for Hyperbaric oxygen 
includes Pregnancy with carboxyhaemoglobin level > 15%, Carboxyhaemoglobin >25%, evi-
dence of acute myocardial ischemia, and severe metabolic acidosis [56].
17. Iron toxicity
Iron tablets are usually available in homes with small children and young women especially 
pregnant women. Because of its colour, sugar taste and appearance like a candy make iron 
tablet more attractive for accidental ingestion for children [57].
17.1. Mechanism of action
Iron exerts a direct corrosive effect on the gastrointestinal tract at high plasma concentrations; 
it also possesses cytotoxic actions, particularly on the liver, leading to hepatocellular necrosis. 
Additionally, iron has a direct cardio- toxic effect acting as a negative inotrope and inhib-
its thrombin leading to a coagulopathy independent of hepatotoxicity. The direct corrosive 
effects and cellular toxicity contribute to metabolic acidosis [58].
17.2. Clinical features
Serious iron poisoning usually causes symptoms within 6 h of the overdose and if the ingested 
elemental iron more than 20 mg/kg body, the symptoms of iron poisoning typically occur in 
5 stages:
Stage 1 (within 6 h after the overdose): Symptoms include vomiting, vomiting blood, diar-
rhoea, abdominal pain, irritability and drowsiness. If poisoning is very serious, rapid breath-
ing, a rapid heart rate, coma, unconsciousness, seizures, and low blood pressure may develop.
Stage 2 (6–48 h after the overdose): condition can appear to improve (there is often a latent 
phase with minimal symptoms which may last up to 24 h and may be misinterpreted as an 
apparent recovery).
Stage 3 (12–48 h after the overdose): Very low blood pressure (shock), fever, bleeding, jaun-
dice, liver failure, metabolic acidosis and seizures can develop.
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Stage 4 (2–5 days after the overdose): The liver fails and people may die from shock, bleeding, 
and blood-clotting abnormalities. Sugar levels in the blood can decrease. Confusion and slug-
gishness (lethargy) or coma may develop.
Stage 5 (2–5 weeks after the overdose): The stomach or intestines can become blocked by scars 
[59, 60].
17.3. Treatment
First step stabilize the air way, breathing and circulation. An abdominal x-ray may be helpful 
to confirm the presence of iron tablets. Consider GI decontamination by whole bowel irriga-
tion if the patient is stable and has no contraindications, especially for large ingestions of 
modified release products, providing the airway can be protected. Activated charcoal does 
not bind iron. Asymptomatic patients need observation for 6 h and serum iron levels less than 
300–350 mcg/dL may be discharged.
Chelation therapy with deferoxamine is indicated for patients with serum iron levels >350 mcg/dL 
and have evidence of toxicity, or levels of >500 mcg/dL regardless of signs or symptoms. In 
patients with significant clinical manifestations of toxicity persistent emesis, metabolic acido-
sis, chelation therapy should not be delayed while one awaits serum iron levels. Haemodialysis 
does not remove iron effectively but should be considered on a supportive basis for acute renal 
failure as this will facilitate removal of the iron-deferoxamine complex [61, 62].
18. Toxic alcohol poisoning
The term toxic alcohol has generally referred to isopropanol, methanol, and ethylene glycol 
(EG). Poisoning involving toxic alcohols are relatively uncommon, but remain important 
causes of suicide or epidemic poisonings; Mortality and morbidity of toxic alcohols are high 
if prompt diagnosis and treatment are not initiated rapidly [63, 64].
18.1. .Mechanism of action and clinical features
Methanol also called methyl alcohol is found in paint removers or photocopying fluid, de-
icing products and windshield wiper fluid. Methanol metabolism in the liver by alcohol dehy-
drogenase to formaldehyde. Aldehyde dehydrogenase then rapidly converts formaldehyde 
to formic acid with no appreciable accumulation of formaldehyde in the blood.
The formic acid inhibits cytochrome c in the mitochondria, shifting the cell to anaerobic gly-
colysis, leading to lactic acid accumulation. The clinical features of methanol poisoning are 
the triad of severe anion gap metabolic acidosis, visual changes, and mental status depres-
sion. Other methanol intoxication symptoms include headache, light-headedness, nausea, 
vomiting, abdominal pain and dyspnoea. Methanol may produce pancreatitis by direct toxic 
effect on the pancreas.
Ethylene glycol is found in radiator antifreeze, metal cleaners, and degreasing agents. It has no 
smell or colour and tastes sweet. Ethylene glycol is metabolized in the liver to glycolaldehyde 
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by alcohol dehydrogenase. Glycolaldehyde is then converted to glycolic acid which is then 
converted to oxalic acid. Oxalic acid combines with serum calcium to form the classic calcium 
oxalate crystals found in the urine of patients who have consumed ethylene glycol.
Ethylene glycol causes an elevated anion gap metabolic acidosis. The neurologic effects of ethyl-
ene glycol are coma, seizures, meningism, muscle spasms, and paralysis of the extraocular mus-
cles. It can also affect the heart and lungs, causing tachycardia, hyperventilation, ARDS, and heart 
failure. Hypocalcaemia and resulting QT prolongation are due to serum calcium combining with 
oxalic acid. Lastly, kidney failure is due to these calcium crystals depositing into renal tubules.
Isopropyl alcohol is found in solvents and disinfectants. It is also found in mouthwashes, lotions, 
as well as rubbing alcohol and hand sanitizers. It is also hepatically metabolized by alcohol dehy-
drogenase to acetone. Isopropanol produces an increased osmole gap; however, it normally does 
not produce a metabolic acidosis unless concomitant hypotension causes lactic acidosis. It can 
cause haemorrhagic gastritis and profound inebriation with cerebellar signs and coma [64–70].
18.2. Investigations
An osmolar gap more than 10 mOsm/kg is suggestive of ethylene glycol, methanol, isopropanol, 
ethylene oxide, or acetone toxicity. A high anion gap metabolic acidosis may be revealed at later 
stages of methanol and ethylene glycol poisoning. Hypoglycaemia may be detected with isopro-
panol, while hyperglycaemia and hypocalcaemia may be detected in methanol and ethylene gly-
col poisonings, respectively. Hyperkalaemia due to acidosis is observed in methanol and ethylene 
glycol poisoning, whereas hypokalaemia due to vomiting may occur in ethanol intoxication.
Urine calcium oxalate crystals can be seen in ethylene glycol intoxication. These findings 
should be evaluated together with the other manifestations and observations [71, 72].
18.3. Treatment
Any patient with serious poisoning may present in a critical condition. As with all poisoned 
patients, initial stabilization must be instituted before other possible treatments can be 
employed Initial evaluation should be focused on the improvement of vital signs: airway, 
respiration and circulation.
Consider toxic alcohol poisoning in a patient with an unexplained elevated anion gap meta-
bolic acidosis and elevated osmolar gap.
Fomepizole competitively inhibits alcohol dehydrogenase, which is involved in the metabo-
lism of all alcohols, including ethanol. It is given to prevent the build-up of toxic metabolites 
from ethylene glycol (glycolic acid, glyoxylic acid, and oxalic acid) and methanol (formic acid) 
whose deposition in tissues can cause irreparable damage.
Fomepizole is indicated for methanol or ethylene glycol ingestion resulting in a metabolic 
acidosis with an elevated osmolar gap and a serum Methanol or ethylene glycol level of at 
least 20 mg/dL.
Haemodialysis is indicated for toxic alcohol poisoning with an elevated osmolar gap and/
or severe metabolic acidosis refractory to standard therapy, refractory hypotension, or end 
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organ damage (i.e. acute renal failure. Vitamin Supplementation: Give folic or folinic acid to 
patients with methanol toxicity to divert metabolism away from formic acid to carbon dioxide 
and water. Give folic acid, pyridoxine, and thiamine to patients with EG toxicity to divert 
metabolism to nontoxic metabolites [73–76].
19. Organophosphates poisoning
Organophosphates (OP) are used in insecticides for domestic and agricultural use. They are 
also the main toxins in nerve gases like Sarin. OP pesticide self-poisoning is a major clinical 
and public-health problem across much of rural Asia [77].
19.1. Mechanism of action
The most serious poisoning of OP occurs by ingestion; cutaneous absorption and inhalation 
of sprays rarely cause serious toxicity. OP is extremely toxic pesticides, which produce acetyl-
choline excess with muscarinic, nicotinic and CNS effects.
19.2. Clinical features
Patients present with degrees of cholinergic crisis, usually within 4 h of ingestion or exposure. 
Specific manifestations include: Muscarinic manifestations like bronchospasm, vomiting, 
pinpoint pupils, bradycardia and hypotension, excessive sweating, lacrimation, salivation, 
profuse diarrhoea and urination (Table 4).
Over-stimulation of nicotinic receptors causes tachycardia, hypertension and sweating. 
Accumulation of acetylcholine at the neuromuscular junction causes initial stimulation fol-
lowed by depolarization and paralysis. This appears first as fasciculations, cramps and muscle 
weakness. Central nervous system (CNS) effects include delirium, coma and seizures. Most 
deaths are due to respiratory failure. Toxicity from gradual, cumulative exposure may be 
much more subtle. These patients commonly exhibit vague confusion or other central nervous 
system complaints; mild visual disturbances; or chronic abdominal cramping, nausea, and 
diarrhoea. A unique effect of organophosphorus insecticides results from “aging,” the irre-
versible conformational change that occurs when the organophosphorus agent is bound to the 
Diarrhoea
Urination
Miosis
Bronchospasm
Emesis
Lacrimation
Salivation
Table 4. DUMBELS mnemonic for signs of cholinergic excess.
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cholinesterase enzyme for a prolonged time, causing clinical effects to persist for a prolonged 
time. On average, some aging for commercial organophosphorus agents will occur by 48 h 
but may take longer. The intermediate syndrome is distinct from OP in the following ways: 
start within 24–96 h after recovery from acute cholinergic crisis, cranial nerves INNERVATED 
muscle and proximal muscles weakness, and rapid clinical recovery over 4–18 days. Any 
patient with a clinically apparent cholinergic syndrome should be treated empirically without 
waiting for laboratory confirmation of decreased cholinesterase activity [78].
19.3. Treatment
Medical management of OP pesticide poisoning demands close observation, timely insti-
tution of antidote in adequate doses and duration and good supportive. The Treating staff 
should wear protective clothing. The patient’s clothes should be removed and destroyed and 
the patient should be showered in a designated decontamination area.
Treatment includes: resuscitation of patients giving oxygen, a muscarinic antagonist (usually 
atropine), fluids and an acetylcholinesterase reactivator (an oxime that reactivates acetylcho-
linesterase by removal of the phosphate group).
Respiratory support is given as necessary. Patients must be carefully observed after stabiliza-
tion for changes in atropine needs, worsening respiratory function because of intermediate 
syndrome, and recurrent cholinergic features occurring with fat-soluble OP [79].
20. Conclusion
Poisoned patient in emergency department have unique Approach because of difficulties in 
obtain history, poisoned patients need careful physical examination looking for toxidromes 
or sign of illegal drugs abuse. Intoxicated patient’s management started with resuscitation 
and stabilization of air way, breathing and circulation. Consider decontamination in early 
time post ingestion. Most of the patient need laboratory test includes full cell count and elec-
trolytes and kidney functions, specific drug level. Paracetamol level must be send for every 
present with history intestinal over dose. Symptomatic treatment is cornerstone treatment 
for post intoxicated patient also antidotes need for specific substances in specific conditions. 
Finally physicians in emergency department need to call the local poisoning centre to help 
them in management.
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